REG - Celtic PLC - Issue of Equity

CelticAnnouncement

01/11/2018 11:00

RNS Number : 0256G
Celtic PLC
01 November 2018
 


CELTIC PLC (the "Company")
Issued share capital
 
As a result of the conversion of 10,879 Convertible Cumulative Preference Shares of 60p each and 2,023 Convertible Preferred Ordinary Shares of 100p each, Celtic PLC's issued share capital as at 31 October 2018 was as follows:
 



93,894,108


Ordinary Shares of 1p each ("Ordinary Shares")




12,901,256


Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")




15,882,866


Convertible Cumulative Preference Shares of 60p each ("CCP Shares")




654,898,838


Deferred Shares of 1p each ("Deferred Shares")



      
CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 
 
The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.
 
Application has been made for the admission of 15,086 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will commence on 6 November 2018.
 
Enquiries:
 



Company
Michael Nicholson, Company Secretary


 
0141 551 4298




 
Canaccord Genuity Limited
Simon Bridges, Nominated Adviser


 
 
020 7523 8350



 
               
 
                               
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBFLFBVFFLFBE